CREDIT SUISSE AG/ - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 1 filers reported holding EIDOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$1,267,000
+329.5%
9,632
+64.5%
0.00%
Q3 2020$295,000
+6.9%
5,857
+1.3%
0.00%
Q2 2020$276,000
+0.4%
5,784
+3.1%
0.00%
Q1 2020$275,000
-82.1%
5,608
-79.1%
0.00%
-100.0%
Q4 2019$1,538,000
+136.3%
26,792
+47.9%
0.00%0.0%
Q3 2019$651,00018,1090.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$53,563,00020.44%
Board of Trustees of The Leland Stanford Junior University 265,670$12,664,00010.90%
Opaleye Management Inc. 315,550$14,634,0002.96%
RA Capital Management 2,162,671$103,095,0002.01%
Cormorant Asset Management, LP 1,055,302$50,306,0001.92%
Parkman Healthcare Partners LLC 41,085$1,959,0000.55%
Redmile Group, LLC 593,842$28,308,0000.52%
Perceptive Advisors 686,922$30,115,0000.49%
HighVista Strategies LLC 10,596$505,0000.42%
Ikarian Capital, LLC 100,000$4,767,0000.38%
View complete list of EIDOS THERAPEUTICS INC shareholders